Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth, NovioGendix Share $1.1M Grant for Bladder Cancer Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today announced it will be sharing a $1.1 million grant with NovioGendix to develop tumor markers for bladder cancer.

The grant comes from Eurotrans-Bio, a European Commission initiative to foster cross-border R&D between companies and academia in the biotechnology space.

MDxHealth and NovioGendix together will use the funds to discover and validate tumor markers that may be predictive of tumor progression into the muscle in developing invasive-stage bladder cancer. The partners will use DNA methylation technologies, DNA sequencing, and RNA expression profiles on clinical samples collected from bladder cancer patients from the urology department at Radboud University Nijmegen Medical Centre in the Netherlands.

NovioGendix is a molecular diagnostics firm spun out of RUNMC.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.